Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8747902 Modified release formulations containing drug-ion exchange resin complexes

Patent 8747902 was granted and assigned to Tris Pharma on June, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Ketan Mehta0

Yu-Hsing Tu0

Date of Patent

June 10, 2014

Patent Application Number

14065842

Date Filed

October 29, 2013

Patent Citations Received

US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12109186 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115142 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115143 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 11666546 GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming system

0

US Patent 11766418 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

...

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8747902 Modified release formulations containing drug-ion exchange resin complexes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool